Cargando…
Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717152/ https://www.ncbi.nlm.nih.gov/pubmed/33156920 http://dx.doi.org/10.1093/ajh/hpaa177 |
| _version_ | 1783619292486434816 |
|---|---|
| author | Hennessy, Sean Cohen, Jordana B |
| author_facet | Hennessy, Sean Cohen, Jordana B |
| author_sort | Hennessy, Sean |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7717152 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77171522020-12-09 Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence Hennessy, Sean Cohen, Jordana B Am J Hypertens Commentaries Oxford University Press 2020-11-06 /pmc/articles/PMC7717152/ /pubmed/33156920 http://dx.doi.org/10.1093/ajh/hpaa177 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights) |
| spellingShingle | Commentaries Hennessy, Sean Cohen, Jordana B Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence |
| title | Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence |
| title_full | Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence |
| title_fullStr | Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence |
| title_full_unstemmed | Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence |
| title_short | Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence |
| title_sort | angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and covid-19: demonstrating the actionability of real-world evidence |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717152/ https://www.ncbi.nlm.nih.gov/pubmed/33156920 http://dx.doi.org/10.1093/ajh/hpaa177 |
| work_keys_str_mv | AT hennessysean angiotensinconvertingenzymeinhibitorsangiotensinreceptorblockersandcovid19demonstratingtheactionabilityofrealworldevidence AT cohenjordanab angiotensinconvertingenzymeinhibitorsangiotensinreceptorblockersandcovid19demonstratingtheactionabilityofrealworldevidence |